Bone Marrow Transplantation - Table of Contents alert Volume 48 Issue 8

TABLE OF CONTENTS Volume 48, Issue 8 (August 2013) In this issue Reviews Original Articles Letters to the Editor Book Review Also new AOP Advertisement   Just one of many high quality articles Frontiers in Oncology has to offer:  Cytotoxic capacity of IL-15-stimulated cytokine-induced killer cells against human acute myeloid leukemia and rhabdomyosarcoma in humanized preclinical mouse models (open access) In this study, Peter Bader and colleagues focus on the principal biological characteristics and engraftment sites of human acute myeloid leukemia (AML) and RMS cells injected via the tail vein in sublethally irradiated NSG mice. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Hot off the press!! Read this recent study published in British Journal of Cancer:  The benefits and harms of breast cancer screening: an independent review  Like what you see? Spread the word. [Twitter]  [Facebook]  Reviews Top Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant? M Hamadani Bone Marrow Transplant 2013 48: 1013-1021; advance online publication, September 24, 2012; 10.1038/bmt.2012.182 Abstract | Full Text Light-chain amyloidosis: SCT, novel agents and beyond M Rosenzweig, S Giralt and H Landau Bone Marrow Transplant 2013 48: 1022-1027; advance online publication, October 29, 2012; 10.1038/bmt.2012.199 Abstract | Full Text Original Articles Top HISTOCOMPATIBILITY AND DONOR SELECTION Donor choice according to age for allo-SCT for AML in complete remission F Ayuk, T Zabelina, F Wortmann, H Alchalby, C Wolschke, H Lellek, U Bacher, A Zander and N Kröger Bone Marrow Transplant 2013 48: 1028-1032; advance online publication, February 18, 2013; 10.1038/bmt.2013.14 Abstract | Full Text STEM CELL PROCUREMENT Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer Center M Pozotrigo, N Adel, H Landau, A Lesokhin, N Lendvai, D J Chung, D Chimento, E Riedel, X Chen, L Reich, R Comenzo, S Giralt and H Hassoun Bone Marrow Transplant 2013 48: 1033-1039; advance online publication, January 21, 2013; 10.1038/bmt.2012.281 Abstract | Full Text CORD BLOOD STEM CELLS Co-transplantation of third-party umbilical cord blood-derived MSCs promotes engraftment in children undergoing unrelated umbilical cord blood transplantation S H Lee, M W Lee, K H Yoo, D S Kim, M H Son, K W Sung, H Cheuh, S J Choi, W Oh, Y S Yang and H H Koo Bone Marrow Transplant 2013 48: 1040-1045; advance online publication, February 11, 2013; 10.1038/bmt.2013.7 Abstract | Full Text Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation R Romee, D J Weisdorf, C Brunstein, J E Wagner, Q Cao, B R Blazar, N S Majhail, G M Vercellotti, J S Miller and M Arora Bone Marrow Transplant 2013 48: 1046-1049; advance online publication, February 18, 2013; 10.1038/bmt.2013.8 Abstract | Full Text PEDIATRIC TRANSPLANTS Long-term outcome of non-ablative booster BMT in patients with SCID C L Teigland, R E Parrott and R H Buckley Bone Marrow Transplant 2013 48: 1050-1055; advance online publication, February 11, 2013; 10.1038/bmt.2013.6 Abstract | Full Text ALLOGRAFTING Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience G A Hale, M Arora, K W Ahn, W He, B Camitta, M R Bishop, M Bitan, M S Cairo, K Chan, R W Childs, E Copelan, S M Davies, M A D Perez, J J Doyle, R P Gale, M G Vicent, B N Horn, A A Hussein, S Jodele, N R Kamani, K A Kasow, M Kletzel, H M Lazarus, V A Lewis, K C Myers, R Olsson, M Pulsipher, M Qayed, J E Sanders, P J Shaw, S Soni, P J Stiff, E A Stadtmauer, N T Ueno, D A Wall and S A Grupp Bone Marrow Transplant 2013 48: 1056-1064; advance online publication, February 18, 2013; 10.1038/bmt.2012.284 Abstract | Full Text Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers A Bazarbachi, M Labopin, A Ghavamzadeh, S Giebel, H Al-Zahrani, S Ladeb, G Leone, F Abdel-Rahman, V Liso, A A Hamidieh, W Rasheed, A Ibrahim, A Alabdulaaly, S Kyrcz-Krzemien, R Arnold, M A Kharfan-Dabaja, K Alimoghaddam, M Aljurf and M Mohty Bone Marrow Transplant 2013 48: 1065-1069; advance online publication, January 28, 2013; 10.1038/bmt.2013.1 Abstract | Full Text CD34+ lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT F Rosenow, A Berkemeier, U Krug, C Müller-Tidow, J Gerss, G Silling, C Groth, P Wieacker, N Bogdanova, R Mesters, T Büchner, J Kienast, W E Berdel and M Stelljes Bone Marrow Transplant 2013 48: 1070-1076; advance online publication, February 4, 2013; 10.1038/bmt.2013.2 Abstract | Full Text The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis S Kako, S Morita, H Sakamaki, H Iida, M Kurokawa, K Miyamura, H Kanamori, M Hara, N Kobayashi, Y Morishima, K Kawa, T Kyo, T Sakura, I Jinnai, J Takeuchi, Y Miyazaki, S Miyawaki, K Ohnishi, T Naoe and Y Kanda Bone Marrow Transplant 2013 48: 1077-1083; advance online publication, February 4, 2013; 10.1038/bmt.2013.4 Abstract | Full Text Haploidentical hematopoietic SCT increases graft-versus-tumor effect against renal cell carcinoma T Budak-Alpdogan, C T Sauter, C P Bailey, C S Biswas, M M Panis, S Civriz, N Flomenberg and O Alpdogan Bone Marrow Transplant 2013 48: 1084-1090; advance online publication, February 25, 2013; 10.1038/bmt.2013.9 Abstract | Full Text Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients A W Loren, R Brazauskas, E J Chow, M Gilleece, J Halter, D A Jacobsohn, S Joshi, J Pidala, G P Quinn, Z Wang, J F Apperley, L J Burns, G A Hale, B M Hayes-Lattin, R Kamble, H Lazarus, P L McCarthy, V Reddy, A B Warwick, B J Bolwell, C Duncan, G Socie, M L Sorror, J R Wingard and N S Majhail Bone Marrow Transplant 2013 48: 1091-1097; advance online publication, February 18, 2013; 10.1038/bmt.2013.13 Abstract | Full Text POST-TRANSPLANT EVENTS Identification of risk factors for bronchiolitis obliterans syndrome after reduced toxicity conditioning before hematopoietic cell transplantation J Duque-Afonso, G Ihorst, R Wäsch, H Bertz, J Müller-Quernheim, J Finke, A Prasse and R Marks Bone Marrow Transplant 2013 48: 1098-1103; advance online publication, February 4, 2013; 10.1038/bmt.2013.3 Abstract | Full Text Large granular lymphocytosis and its impact on long-term clinical outcomes following allo-SCT D (Dong Hwan) Kim, G Al-Dawsari, H Chang, T Panzarella, V Gupta, J Kuruvilla, J H Lipton and H A Messner Bone Marrow Transplant 2013 48: 1104-1111; advance online publication, February 11, 2013; 10.1038/bmt.2013.5 Abstract | Full Text Long-term follow up of patients proceeding to transplant using plerixafor mobilized stem cells and incidence of secondary myelodysplastic syndrome/AML A Deol, J Abrams, A Masood, Z Al-Kadhimi, M H Abidi, L Ayash, L G Lum, V Ratanatharathorn and J P Uberti Bone Marrow Transplant 2013 48: 1112-1116; advance online publication, March 11, 2013; 10.1038/bmt.2013.10 Abstract | Full Text Incident hyperglycemia, parenteral nutrition administration and adverse outcomes in patients with myeloma admitted for initial auto-SCT P M Sheean, J M Kilkus, D Liu, J Maciejewski and C A Braunschweig Bone Marrow Transplant 2013 48: 1117-1122; advance online publication, February 18, 2013; 10.1038/bmt.2013.11 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium N Treister, X Chai, B Kurland, S Pavletic, D Weisdorf, J Pidala, J Palmer, P Martin, Y Inamoto, M Arora, M Flowers, D Jacobsohn, M Jagasia, S Arai, S J Lee and C Cutler Bone Marrow Transplant 2013 48: 1123-1128; advance online publication, January 28, 2013; 10.1038/bmt.2012.285 Abstract | Full Text Acute gut GVHD in children: does skin involvement matter? A Gassas, L Sung, A Dupuis, T Schechter, M Egeler and M Ali Bone Marrow Transplant 2013 48: 1129-1132; advance online publication, March 11, 2013; 10.1038/bmt.2013.15 Abstract | Full Text INFORMATION ABOUT TRANSPLANTS Potential adult sibling stem cell donors’ perceptions and opinions regarding an information and care model A Kisch, S Lenhoff, M Bengtsson and I Bolmsjö Bone Marrow Transplant 2013 48: 1133-1137; advance online publication, January 21, 2013; 10.1038/bmt.2012.283 Abstract | Full Text Letters to the Editor Top Pseudo-autologous hematopoietic SCT as treatment for a patient with multiple myeloma who relapsed following an allogeneic hematopoietic SCT E Palfreyman, K Song and S Nantel Bone Marrow Transplant 2013 48: 1138; advance online publication, February 18, 2013; 10.1038/bmt.2013.12 Full Text Sjögren’s syndrome associated chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) treated with autologous and subsequently allogeneic haematopoietic SCT (HSCT) S Bregante, F Gualandi, M T van Lint, A Schenone, A Bacigalupo and A M Marmont Bone Marrow Transplant 2013 48: 1139-1140; advance online publication, March 18, 2013; 10.1038/bmt.2013.18 Full Text Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantation E Rettinger, H Bonig, S Wehner, G Lucchini, A Willasch, A Jarisch, J Soerensen, R Esser, C Rossig, T Klingebiel and P Bader Bone Marrow Transplant 2013 48: 1141-1143; advance online publication, March 11, 2013; 10.1038/bmt.2013.19 Full Text Book Review Top Hematology: basic principles and practice J Goldman Bone Marrow Transplant 2013 48: 1144; 10.1038/bmt.2013.77 Full Text Advertisement New Rising Impact Factor Leukemia celebrates a new Impact Factor of 10.164* and the journal is now ranked No. 2 in Hemtology and No. 8 in Oncology. Thank you for your support of the Leukemia. Read a free review: Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia *2012 Journal Citation Reports® (Thomson Reuters, 2013)     Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.